marijuana stocks
The Green Organic Dutchman and Epican Receive Second Retail Licence from the CLA, Announce Opening of Second Retail Dispensary in Jamaica

Montego Bay is a popular tourist destination and Jamaica’s second largest city. It is also a major port of call for cruise ships, a destination for duty free shopping and home to the country’s largest airport. The Montego Bay flagship dispensary, located on the main tourist shopping strip, is the second Epican dispensary to open, after Epican’s Herb House in Kingston which opened in June 2018 . Epican is the first fully integrated company to have obtained a second retail licence from Jamaica’s Cannabis Licensing Authority (CLA).

Epican plans to open three additional Herb Houses on the island. In combination with online ordering, these locations will serve the medical needs of Jamaica’s three million residents and over three and a half million annual visitors.

“We are proud of what the team in Jamaica has accomplished. Epican’s Montego Bay store is a bright and well-designed space ideally located to serve local and visiting patients with Epican’s locally produced premium organic cannabis,” commented Brian Athaide , CEO of TGOD. “Our Kingston location witnessed increasing sales volumes; setting the stage for the grand opening of an Epican Herb House in Jamaica’s largest tourist hub. It is an important milestone toward further expansion for Epican and TGOD in Jamaica .”

Jamaica is recognized as a premier destination for cannabis, and Epican has deep roots in the country. The founders, the McKenzie brothers, have been at the forefront of the nation’s burgeoning medical cannabis industry, including advocacy for the responsible development of the sector. Epican was awarded the country’s historic first cultivation licence.

“Today is yet another celebration for Epican and TGOD,” stated Karibe McKenzie, CEO of Epican. “We have worked tirelessly to provide a fully-integrated solution delivering high-quality medical cannabis to Jamaicans and tourists alike, and the response in Kingston has been overwhelming. We can’t wait to make our mark in Montego Bay .”

TGOD owns 49.18% of Epican, and the joint organization is partnering to construct a GMP compliant facility in Jamaica . Upon receiving the licence for this site expansion, Epican will cultivate premium strains for the Jamaican and international market.

On Behalf of the Board of Directors,

The Green Organic Dutchman Holdings Ltd.

ABOUT THE GREEN ORGANIC DUTCHMAN HOLDINGS LTD.

The Green Organic Dutchman Holdings Ltd. (TGOD.TO) (TGODF) is a publicly traded, premium global organic cannabis company, with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. TGOD also has organic hemp CBD oil operations in Canada , and through its wholly owned subsidiary HemPoland distributes premium hemp CBD oil in the EU. The Company grows high quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a planned capacity of 219,000 kgs and is building 1,643,600 sq. ft. of cultivation and processing facilities across Ontario , Quebec , Jamaica and Denmark .

TGOD’s Common Shares and warrants issued under the indenture dated November 1, 2017 trade on the TSX under the symbol “TGOD” and “TGOD.WT”, respectively.

on The Green Organic Dutchman Holdings Ltd., please visit www.tgod.ca.

Forward-Looking Information Cautionary Statement

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward looking statements in this release includes, but is not limited to,, statements about future dispensary openings in Montego Bay and throughout Jamaica , statements about future facility construction, statements about the achievement of certain certifications in connection with its facilities, statements about the receipt of any regulatory permits or licences,, statements about the offering of any particular products by the Company in any jurisdiction and statements regarding the future performance of the Company. Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Integrated Cannabis Company, Inc. (ICNAF) Announces Fall 2018 Collaboration to Launch CBD Products

Integrated Cannabis Company, Inc. Announces Fall 2018 Collaboration to Launch CBD Products…

GT Biopharma Inc. (GTBP) Announces Completion of Dosing in Phase 1 Clinical Trial of GTP-004

  GT Biopharma Announces Completion of Dosing in Phase 1 Clinical Trial…

$EDXC Updates Shareholders

Endexx Provides Shareholder Update 2014/2015 CAVE CREEK, AZ–(Marketwired – Jan 6, 2015)…

Aurora Cannabis Inc. (ACB) and Vectura Fertin Pharma, Inc. announce commercial collaboration

Aurora Cannabis and Vectura Fertin Pharma, Inc. announce commercial collaboration Aurora Cannabis…